UCB Announces Positive Phase 3 Studies for Bimekizumab in Hidradenitis Suppurativa ...Middle East

PR Newswire - News
UCB Announces Positive Phase 3 Studies for Bimekizumab in Hidradenitis Suppurativa
Top-line results show that the two Phase 3 studies, BE HEARD I and BE HEARD II, met their primary and key secondary endpoints with statistical significance and consistent clinical relevance First Phase 3 evidence to suggest that targeting IL-17F in addition to IL-17A may be a promising...

Hence then, the article about ucb announces positive phase 3 studies for bimekizumab in hidradenitis suppurativa was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( UCB Announces Positive Phase 3 Studies for Bimekizumab in Hidradenitis Suppurativa )

Apple Storegoogle play

Last updated :

Also on site :